Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000082604 | SCV000114646 | benign | not specified | 2013-11-04 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000082604 | SCV000192097 | benign | not specified | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000082604 | SCV000315890 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000463305 | SCV000561867 | benign | Developmental and epileptic encephalopathy, 1; Intellectual disability, X-linked, with or without seizures, arx-related | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316276 | SCV000851632 | likely benign | Inborn genetic diseases | 2019-03-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001647067 | SCV001856749 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001647067 | SCV001962612 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | ARX: BS2 |
OMIM | RCV000011954 | SCV000032188 | uncertain significance | Intellectual disability, X-linked, with or without seizures, arx-related | 2011-01-01 | no assertion criteria provided | literature only |